Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
This piece explains the benefits of using rolling returns to assess index fund performance, highlighting consistency, cycles, and risk insights.
25,257 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A single, fixable flaw undermines most households' budgets: the failure to automate saving and bill payments. Here's ...
Block announces a sweeping AI-driven layoff, cutting roughly 4,000 jobs and shrinking headcount to under 6,000. The m...
Markets swing as geopolitical tensions flare between the U.S. and Iran. This analysis traces the past CIA plan and ex...
A landmark view from a high-profile venture capitalist signals a shift in career guidance as AI reshapes the job mark...
A Hong Kong-based stablecoin payments processor plans a $150 million pre-IPO round to fuel a possible U.S. listing th...
BitGo expands institutional access by enabling OTC entry to prediction markets through a new alliance with Susquehann...
Scotiabank boosted Cameco's price target to $175 as a global push for nuclear power gains traction and a new supply d...
Brent crude charts flashed a pattern not seen in 36 years, triggering fresh volatility bets. Analysts say the rarity ...
Broadcom and Microsoft posted AI-driven quarters, underscoring two distinct strategies: Broadcom sells AI chips to hy...
AI disruption is reshaping entry-level jobs, pushing the next generation to consider space-based careers. This report...
Bitcoin fell to the $75,000 area after a volatile week of gains and selling. On-chain flows, high-profile bets, and F...